Noida, India

Raghava Reddy Kethiri

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Noida, IN (2014 - 2017)
  • Subramanyapura, IN (2023)
  • Bengaluru, IN (2018 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: Raghava Reddy Kethiri: Pioneering Innovations in Cancer Treatment

Introduction

Raghava Reddy Kethiri, an innovative inventor based in Noida, India, has made significant contributions to the field of pharmaceuticals with a total of 15 patents to his name. His work primarily focuses on developing novel compounds that target critical pathways associated with various medical conditions, most notably cancer.

Latest Patents

Kethiri’s latest inventions include patents related to heterocyclic inhibitors of ERK1 and ERK2, which are instrumental in cancer therapy. These patent applications highlight the development of novel heterocyclic compounds and their pharmaceutically acceptable salts, offering methods for their preparation. By administering these compounds to patients, they effectively inhibit the RAS/RAF/MEK/ERK pathway, aiding in the treatment of diseases characterized by abnormal cellular proliferation, particularly cancer.

Additionally, Kethiri has invented substituted piperidine derivatives designed to inhibit the ATF4 pathway, which can be beneficial in treating a range of conditions, including cancer, pre-cancerous syndromes, and diseases linked to activated unfolded protein response pathways. These innovations not only extend their applications to various neurological diseases but also include conditions such as Alzheimer’s, Parkinson’s, and cardiovascular diseases.

Career Highlights

Kethiri has worked with renowned companies like Asana Biosciences and GlaxoSmithKline Intellectual Property Development Limited. His career reflects a strong commitment to advancing medical science through innovative therapies and pharmaceutical developments.

Collaborations

Throughout his career, Kethiri has collaborated with notable colleagues, including Roger Astbury Smith and Purushottam M Dewang. These partnerships have likely contributed to the breadth and impact of his research and patents.

Conclusion

Raghava Reddy Kethiri stands out as a pivotal figure in the pharmaceutical industry, specifically in cancer research and treatment innovation. His extensive work in developing novel compounds illustrates a dedication to addressing complex medical challenges through advanced scientific methodologies. As he continues his endeavors, his contributions are set to bring transformative changes to healthcare and treatment paradigms.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…